Brady Stephen R 4
4 · Tempest Therapeutics, Inc. · Filed Oct 13, 2023
Insider Transaction Report
Form 4
Brady Stephen R
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2023-10-11+725,000→ 725,000 totalExercise: $9.77Exp: 2033-10-10→ Common Stock (725,000 underlying)
Footnotes (1)
- [F1]25% of the award shall vest on October 11, 2024 and the remainder of the award shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date.